The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Open accessAbstract
In efforts to inform public health decision makers, the Global Burden of Diseases, Injuries, and Risk Factors 2010 (GBD2010) Study aims to estimate the burden of disease using available parameters. This study was conducted to collect and analyze available prevalence data to be used for estimating the hepatitis C virus (HCV) burden of disease. In this systematic review, antibody to HCV (anti-HCV) seroprevalence data from 232 articles were pooled to estimate age-specific seroprevalence curves in 1990 and 2005, and to produce age-standardized prevalence estimates for each of 21 GBD regions using a model-based meta-analysis. This review finds that globally the prevalence and number of people with anti-HCV has increased from 2.3% (95% uncertainty interval [UI]: 2.1%-2.5%) to 2.8% (95% UI: 2.6%-3.1%) and >122 million to >185 million between 1990 and 2005. Central and East Asia and North Africa/Middle East are estimated to have high prevalence (>3.5%); South and Southeast Asia, sub-Saharan Africa, Andean, Central, and Southern Latin America, Caribbean, Oceania, Australasia, and Central, Eastern, and Western Europe have moderate prevalence (1.5%-3.5%); whereas Asia Pacific, Tropical Latin America, and North America have low prevalence (<1.5%). Conclusion : The high prevalence of global HCV infection necessitates renewed efforts in primary prevention, including vaccine development, as well as new approaches to secondary and tertiary prevention to reduce the burden of chronic liver disease and to improve survival for those who already have evidence of liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends
Wasley, A., & Alter, M. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9506 · Cited by 979
Global surveillance and control of hepatitis C
(1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.6120139.x · Cited by 904
Estimating progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27831 · Cited by 620
Hepatitis A virus seroprevalence by age and world region, 1990 and 2005
Jacobsen, K. H., & Wiersma, S. T. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.037 · Cited by 569
Self-citationMultilevel (Hierarchical) Modeling: What It Can and Cannot Do
Gelman, A. (2006) · Technometrics · doi:10.1198/004017005000000661 · Cited by 557
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 523
Global Burden of Disease (GBD) for Hepatitis C
The Global Burden of Hepatitis C Working Group (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003258669 · Cited by 488
Mother-to-infant transmission of hepatitis C virus
Zanetti, A. R., the Lombardy Study Group on Vertical HCV Transmission, Paccagnini, S., Principi, N., Pizzocolo, G., Caccamo, M. L., Amico, E. D., Cambiè, G., & Vecchi, L. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90277-5 · Cited by 454
Reproducible Epidemiologic Research
Peng, R. D., Dominici, F., & Zeger, S. L. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj093 · Cited by 292
Mother–To–Infant Transmission of Hepatitis C Virus
Yeung, L. T. F., King, S. M., & Roberts, E. A. (2001) · Hepatology · doi:10.1053/jhep.2001.25885 · Cited by 269
The history of the “natural history” of hepatitis C (1968–2009)
Seeff, L. B. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01927.x · Cited by 249
Institute of Medicine Recommendations for the Prevention and Control of Hepatitis B and C
Mitchell, A. E., Colvin, H. M., & Beasley, P. R. (2010) · Hepatology · doi:10.1002/hep.23561 · Cited by 195
High hepatitis C incidence in new injecting drug users: a policy failure?
Maher, L., Li, J., Jalaludin, B. B., Chant, K. G., & Kaldor, J. M. (2007) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2007.00007.x · Cited by 122
Payment, compensation and replacement - the ethics and motivation of blood and plasma donation
Farrugia, A., Penrod, J., & Bult, J. M. (2010) · Vox Sanguinis · doi:10.1111/j.1423-0410.2010.01360.x · Cited by 109
Health-exposure modeling and the ecological fallacy
Wakefield, J. C. (2005) · Biostatistics · doi:10.1093/biostatistics/kxj017 · Cited by 104
Global Burden of Disease (GBD) for Hepatitis C The Global Burden of Hepatitis C Working Group
Hutin, Y. J., Kitler, M. E., Dore, G. J., Armstrong, G. L., Dusheiko, G. M., Grob, P. J., Kew, M. C., Marcellin, P., Seeff, L. B., Beutels, P., et al. (2004) · Cited by 78
McIntyre, P. G., Tosh, K., & McGuire, W. L. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005546.pub2 · Cited by 68
Iversen, J., Wand, H. C., Gonnermann, A., & Maher, L. (2010) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2010.04.004 · Cited by 37
Altruism and payment in blood donation
Fernández-Montoya, A. (1997) · Transfusion Science · doi:10.1016/s0955-3886(97)00026-x · Cited by 33
Fu, B., Tom, B. D. M., Delahooke, T., Alexander, G., & Bird, S. M. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.01.015 · Cited by 25
Kuboki, M., Shinzawa, H., Shao, L., Ishibashi, M., Yoshii, E., Suzuki, K., Saito, K., Saito, T., Togashi, H., Takahashi, T. A., et al. (1999) · Liver International · doi:10.1111/j.1478-3231.1999.tb00016.x · Cited by 21
Cited by
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Self-citationLlovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Blach, S., Zeuzem, S., Manns, M., Altraif, I., Duberg, A.-S., Muljono, D. H., Waked, I., Alavian, S. M., Lee, M.-H., Negro, F., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30181-9 · Cited by 2,006
Global epidemiology and genotype distribution of the hepatitis C virus infection
Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., & Razavi, H. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.027 · Cited by 1,903
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Lawitz, E., Mangia, A., Wyles, D., Rodriguez-Torres, M., Hassanein, T., Gordon, S. C., Schultz, M., Davis, M. N., Kayali, Z., Reddy, K. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214853 · Cited by 1,788
Metadata
- Authors
- Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T.
- Venue
- Hepatology
- Published
- 2013-04
- Volume
- 57
- Issue
- 4
- Pages
- 1333-1342
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1977300462
- Cited by
- 2,515
- References
- 25
- FWCI
- 122.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.